APP and fragile X syndrome: Experimental studies in Fmr1KO mice [17] suggest that over-expression of APP/Aβ may contribute to the seizures observed in autism [18] and FXS [4] and that both the over- and under-expression of APP and its metabolites increase the incidence of seizures [7], [17], [19], [20].